Ушбу иш иқтибос қилган ишлар

81 та иш

Иш: Synthetic lethality and DNA damage response targeting in cancer stem cells: a comprehensive review

Targeting cancer stem cells with CAR-based immunotherapy: biology, evidence, and future directions
Kaveh Hadiloo, Parsa Mostanadi, Ali Asadzadeh +2
Шарҳ мақола20256 иқтибос
ABI
CAR-NKT cell therapy: a new promising paradigm of cancer immunotherapy
Kaveh Hadiloo, Safa Tahmasebi, Abdolreza Esmaeilzadeh
Шарҳ мақола20235 иқтибос
ABI
Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance
Gh. Rasool Bhat, Itty Sethi, Hana Q. Sadida +14
Шарҳ мақола20245 иқтибос
ABI
Convergence of evolving artificial intelligence and machine learning techniques in precision oncology
Elena Fountzilas, Tillman Pearce, Mehmet A. Baysal +2
Мақола20254 иқтибос
ABI
Diagnostic technologies for neuroblastoma
Leena Khelifa, Yubing Hu, Jennifer Tall +11
Шарҳ мақола20254 иқтибос
ABI
Functional Roles of CD133: More than Stemness Associated Factor Regulated by the Microenvironment
Ángela Patricia Moreno-Londoño, Martha Robles‐Flores
Шарҳ мақола20233 иқтибос
ABI
Intricate relationship between cancer stemness, metastasis, and drug resistance
Tikam Chand Dakal, Ravi Bhushan, Caiming Xu +7
Шарҳ мақола20243 иқтибос
ABI
Invariant NKT cells with chimeric antigen receptor provide a novel platform for safe and effective cancer immunotherapy
Andras Heczey, Daofeng Liu, Gengwen Tian +10
Мақола20143 иқтибос
ABI
Targeting colorectal cancer (stem-like) cells using LGR5 directed antibody drug conjugates
Daniela Hirsch, Thomas Ried
Бошқа20163 иқтибос
ABI
Targeting Cancer Stem Cells by Genetically Engineered Chimeric Antigen Receptor T Cells
Rowa Y. Alhabbab
Шарҳ мақола20203 иқтибос
ABI
Pre-conditioning modifies the TME to enhance solid tumor CAR T cell efficacy and endogenous protective immunity
John P. Murad, Dileshni Tilakawardane, Anthony K. Park +15
Мақола20213 иқтибос
ABI
CAR-T Cell Therapy for Breast Cancer: From Basic Research to Clinical Application
Yu-Huan Yang, Jiawei Liu, Lü Chen +1
Шарҳ мақола20223 иқтибос
ABI
Cancer cell targeting by CAR-T cells: A matter of stemness
Caterina D’Accardo, Gaetana Porcelli, Laura Rosa Mangiapane +10
Шарҳ мақола20223 иқтибос
ABI
Cancer Stem Cell Metabolism
Fidelia B. Alvina, Arvin M. Gouw, Anne Le
Мақола20213 иқтибос
ABI
Current strategies in cancer gene therapy
Anas El‐Aneed
Шарҳ мақола20042 иқтибос
ABI
The multifaceted roles of PARP1 in DNA repair and chromatin remodelling
Arnab Ray Chaudhuri, André Nussenzweig
Шарҳ мақола20172 иқтибос
ABI
DNA Damage Response in Cancer Therapy and Resistance: Challenges and Opportunities
Dana Jurkovičová, Christiana M. Neophytou, Ana Čipak Gašparović +1
Шарҳ мақола20222 иқтибос
ABI
Biomarkers and targeted therapy for cancer stem cells
Yusheng Liu, Hua Wang
Шарҳ мақола20232 иқтибос
ABI
Redirecting T Cells to Glypican-3 with 4-1BB Zeta Chimeric Antigen Receptors Results in Th1 Polarization and Potent Antitumor Activity
Wenpeng Li, Linjie Guo, Purva Rathi +8
Мақола20162 иқтибос
ABI
Epigenomic profiling of neuroblastoma cell lines
Kristen Upton, Apexa Modi, Khushbu Patel +10
Мақола20202 иқтибос
ABI
Molecular mechanisms of chemo‐ and radiotherapy resistance and the potential implications for cancer treatment
Yaping Liu, Can‐Can Zheng, Yun‐Na Huang +3
Шарҳ мақола20212 иқтибос
ABI
The CD44+/CD24-phenotype is enriched in basal-like breast tumors
Gabriella Honeth, Pär‐Ola Bendahl, Markus Ringnér +7
Мақола20082 иқтибос
ABI
DNA damage-inducing endogenous and exogenous factors and research progress
Nian Liu, Jiahui Du, Jing Ge +1
Шарҳ мақола20242 иқтибос
ABI
Regulation of Metabolic Plasticity in Cancer Stem Cells and Implications in Cancer Therapy
Styliani Papadaki, Angeliki Magklara
Шарҳ мақола20222 иқтибос
ABI
DNA Repair and Therapeutic Strategies in Cancer Stem Cells
Matthew S. Gillespie, Ciara Ward, Clare C. Davies
Шарҳ мақола20232 иқтибос
ABI